<DOC>
	<DOC>NCT00106704</DOC>
	<brief_summary>The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with Type 2 diabetes mellitus.</brief_summary>
	<brief_title>Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients with Type 2 Diabetes Mellitus with inadequate glycemic control Patients with Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>